Oscar Health, Inc. (NYSE: OSCR) announced new individual-market plans for South Florida ahead of the 2026 Open Enrollment window and spotlighted HelloMeno, a menopause-focused offering it and partner Elektra Health describe as the first plan of its kind in the individual market. The rollout lands as Washington headlines around ACA premium tax credits pressure managed-care shares broadly; investors are watching OSCR’s intraday action closely.
Key takeaways
- South Florida expansion for 2026: Oscar unveiled new plans for Miami‑Dade and surrounding counties (including Broward, Palm Beach, Martin, and St. Lucie), effective January 1, 2026, with enrollment via HealthCare.gov.
- HelloMeno spotlight: The program—billed by Oscar and Elektra Health as the individual market’s first menopause plan—features $0 primary care, gynecology and behavioral health visits, along with no‑cost labs, select hormone therapy, and bone density scans. Availability spans multiple states beginning with 2026 coverage.
- Sector context today: Managed‑care stocks fell after comments from former President Trump targeting ACA subsidies; investors are gauging implications for marketplace-focused insurers such as Oscar.
- Backdrop from last week’s earnings: On Nov. 6, Oscar reported Q3 2025 results and reaffirmed full‑year 2025 guidance; leadership said they remain optimistic lawmakers will reach a compromise on ACA tax credits.
What Oscar announced today
Oscar said it will offer new, affordable individual‑market plans across South Florida for plan year 2026, with options available in Miami‑Dade, Broward, Palm Beach, Martin, and St. Lucie counties. Enrollment is through HealthCare.gov during the federal window, and coverage begins January 1, 2026 for those who enroll by mid‑December.
As part of the slate, the company highlighted HelloMeno, developed with Elektra Health and marketed as the first menopause‑focused plan in the ACA individual market. Benefits include $0 virtual and in‑network primary care, gynecology and behavioral health visits, plus no‑cost labs, select hormone therapy, insomnia medications, and bone density scans—aimed at reducing barriers to midlife women’s care. Oscar says the product will be available in a multi‑state footprint for 2026 coverage.
Today’s Miami announcement follows a series of regional press updates last week (e.g., Orlando and Tampa) as Oscar refreshes its 2026 footprint in Florida.
Why the sector is in the headlines
Managed‑care stocks traded lower today after Trump criticized ACA subsidies, calling for a change in how funds flow—an item now entangled with the ongoing federal shutdown debate. While the policy path remains fluid, the remarks weighed on marketplace‑exposed insurers during the session.
Earnings & outlook context (from Nov. 6)
- Q3 2025 results: Oscar reported $2.99B in total revenue for the quarter, a medical loss ratio (MLR) of 88.5%, SG&A ratio of 17.5%, and operating loss of ~$129M. Management reaffirmed full‑year 2025 guidance across metrics.
- Management tone: CEO Mark Bertolini told investors the company is “optimistic” about an eventual legislative compromise on ACA tax credits, even as the individual market may face a “reset moment.” Fierce Healthcare
What this means for consumers in South Florida
- Enrollment window: The 2026 Open Enrollment Period runs Nov. 1, 2025 – Jan. 15, 2026 nationwide; enroll by Dec. 15 for Jan. 1 coverage, or by Jan. 15 for Feb. 1 coverage.
- Where to shop: Most Floridians enroll through HealthCare.gov; state marketplaces vary (e.g., Illinois is moving to a state‑run exchange this cycle).
- Who may benefit from HelloMeno: Women in the menopause transition seeking predictable costs for specialty care and hormone management may find the bundled benefits compelling; check plan documents and provider networks by county before enrolling. (Program details per Elektra/Oscar announcement.)
What this means for investors
- Near‑term watch items: 1) Policy risk around ACA premium tax credits, 2) 2026 enrollment mix and retention in Florida/other announced markets, and 3) progress toward the company’s previously stated profitability goals. Today’s local plan news is incremental, but policy headlines are driving intraday volatility across the group.
- Recent fundamentals: The Q3 reaffirm suggests management’s 2025 plan remains on track despite a higher Q3 MLR; investors will parse January membership updates to assess margin trajectory into 2026.
Essential dates & links (2026 coverage)
- Open Enrollment:Nov. 1, 2025 – Jan. 15, 2026 (federal marketplace). Enroll by Dec. 15 for Jan. 1 coverage; enroll by Jan. 15 for Feb. 1 coverage.
Sources & further reading
- Business Wire/Press: Oscar Launches New Affordable Health Insurance Choices for Southern Florida Individuals, Families, and Businesses (Nov. 10, 2025).
- Elektra Health PR: Elektra Health and Oscar launch HelloMeno (Oct. 20, 2025).
- Reuters: Health insurers slide after Trump targets Obamacare subsidies (Nov. 10, 2025).
- Oscar IR/SEC: Q3 2025 financial results & reaffirmed 2025 outlook (Nov. 6, 2025).
- Fierce Healthcare: Oscar ‘optimistic’ about ACA tax credits compromise, per CEO Mark Bertolini (Nov. 6, 2025).
- CMS/Healthcare.gov: 2026 Marketplace enrollment dates & deadlines.
Disclosure: This article is for information only and is not investment advice. Verify plan details and availability at HealthCare.gov or Oscar’s site before enrolling.
